Aedon® contains the active substance olanzapine.
Aedon® belongs to a group of medicines called antipsychotics.
Aedon® is prescribed to adults.
Olanzapine is indicated for the treatment of schizophrenia. In patients who have responded initially to treatment, olanzapine is effective in maintaining clinical improvement with continued treatment.
Olanzapine is indicated for the treatment of moderate to severe manic episodes. In patients whose manic episode has responded to treatment with olanzapine, olanzapine is indicated for phase prophylaxis in patients with bipolar disorder.
|Strength||Pack size||Dosage form||Appearance|
|2,5 mg||10, 30||Film-coated tablets|
|5 mg||10, 30||Film-coated tablets|
|10 mg||10, 30||Film-coated tablets|
|15 mg||10, 30||Film-coated tablets|
|5 mg||10, 30||Dispersible tablets|
|10 mg||10, 30||Dispersible tablets|
|15 mg||10, 30||Dispersible tablets|